---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038764"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2026-08-17T20:45:24+00:00"
generated_at: "2026-08-17T20:46:12.477000+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Curanex Pharmaceuticals announces 1-for-20 reverse stock split effective Aug 20, 2026

## Summary
- 1-for-20 reverse stock split effective 12:01 a.m. PT on Aug 20, 2026; Nasdaq trading begins split-adjusted that day.
- Pre-split shares ~31,364,812; post-split ~1,568,241 shares outstanding.
- Purpose: regain compliance with Nasdaq's $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).
- No fractional shares; fractional interests rounded up to whole share; new CUSIP number assigned.
- Authorized shares remain 475,000,000; par value $0.0001 unchanged; equity awards proportionally adjusted.

## SEC filing metadata
- accession: 0001493152-26-038764
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2026-08-17T20:45:24+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315226038764/0001493152-26-038764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315226038764/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038764
- JSON: https://secwatch.observer/filing/0001493152-26-038764.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038764.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.